Drugs

Newer Systemic Antifungal Agents: Pharmacokinetics, Safety and Efficacy
pp. 1997-2020(24)
Authors: Helen W. Boucher; Andreas H. Groll; Christine C. Chiou; Thomas J. Walsh

Early-Stage Multiple Sclerosis: What Are the Treatment Options?
pp. 2021-2029(9)
Author: Per Soelberg Sorensen

Antiviral Therapy for Influenza: A Clinical and Economic Comparative Review
pp. 2031-2046(16)
Author: Alexander C. Schmidt

Effect of Immunosuppressive Agents on Long-Term Survival of Renal Transplant Recipients: Focus on the Cardiovascular Risk
pp. 2047-2073(27)
Authors: Johannes M.M. Boots; Maarten H.L. Christiaans; Johannes P. van Hooff

Emtricitabine/Tenofovir Disoproxil Fumarate
pp. 2075-2082(8)
Authors: Toni M. Dando; Antona J. Wagstaff

Emtricitabine/Tenofovir Disoproxil Fumarate: A Viewpoint by Daniel Podzamczer
pp. 2083-2084(2)
Author: Daniel Podzamczer

Emtricitabine/Tenofovir Disoproxil Fumarate: A Viewpoint by Anton Pozniak
pp. 2083-2084(2)
Author: Anton Pozniak

Intravenous Lansoprazole: In Erosive Oesophagitis
pp. 2085-2089(5)
Authors: Toni M. Dando; Greg L. Plosker

Intravenous Lansoprazole: A Viewpoint by Neville Yeomans
pp. 2090-2090(1)
Author: Neville Yeomans

Intravenous Lansoprazole: A Viewpoint by Malcolm Robinson
pp. 2090-2090(1)
Author: Malcolm Robinson

Brivudin (Bromovinyl Deoxyuridine)
pp. 2091-2097(7)
Authors: Susan J. Keam; Therese M. Chapman; David P. Figgitt

Brivudin: A Viewpoint by Peter Wutzler
pp. 2098-2099(2)
Author: Peter Wutzler

Brivudin: A Viewpoint by Gerd Gross
pp. 2098-2099(2)
Author: Gerd Gross

Fosamprenavir: A Review of its Use in the Management of Antiretroviral Therapy-Naive Patients with HIV Infection
pp. 2101-2124(24)
Authors: Therese M. Chapman; Greg L. Plosker; Caroline M. Perry

Cabergoline: A Review of its Use in the Treatment of Parkinson's Disease
pp. 2125-2141(17)
Authors: Monique P. Curran; Caroline M. Perry